Crossmark

OCT biomarkers as predictors of treatment interval in neovascular age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen

Crossref DOI link: https://doi.org/10.1038/s41598-026-36751-4

Published Online: 2026-01-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Jae Hyup

Lee, Sang-Yoon

Jang, Boa

Kim, Young-Gon

Yoon, Chang Ki

Park, Un Chul

Park, Kyu Hyung

Lee, Eun Kyoung
License Information

Text and Data Mining valid from 2026-01-28

Accepted Manuscript valid from 2026-01-28
More Information

Article History

Received: 14 February 2025

Accepted: 16 January 2026

First Online: 28 January 2026

Declarations

:

: The authors declare no competing interests.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Seoul National University Hospital (IRB 2109-124-1257) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was waived because of the retrospective design of the study and the use of deidentified patient information.

Document is current

Any future updates will be listed below